Evatak

N/A

Report date: 2025/03/20 15:48:54

Base Information

Drug NameEvatak
Drug Alias NameEV-1 (Viralytics)echovirus type 1 cancer therapy (Psiron)oncolytic echovirus type 1 therapy (Viralytics)EV-1
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionIntegrin alpha2/beta1 modulators
TargetsIntegrin alpha2/beta1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNewcastle University
China Registration ClassN/A

Develop Information

Active CompaniesViralytics Ltd
Inactive CompaniesViroTarg Pty LtdNewcastle University
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A